nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—Altered state of consciousness—Vincristine—muscle cancer	0.0323	0.0323	CcSEcCtD
Tapentadol—Drug interaction—Vincristine—muscle cancer	0.0161	0.0161	CcSEcCtD
Tapentadol—Drug hypersensitivity—Doxorubicin—muscle cancer	0.0156	0.0156	CcSEcCtD
Tapentadol—Lethargy—Dactinomycin—muscle cancer	0.0124	0.0124	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Dactinomycin—muscle cancer	0.0109	0.0109	CcSEcCtD
Tapentadol—Lung disorder—Methotrexate—muscle cancer	0.0102	0.0102	CcSEcCtD
Tapentadol—Ataxia—Vincristine—muscle cancer	0.0102	0.0102	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Vincristine—muscle cancer	0.00976	0.00976	CcSEcCtD
Tapentadol—Lung disorder—Doxorubicin—muscle cancer	0.00886	0.00886	CcSEcCtD
Tapentadol—Erectile dysfunction—Vincristine—muscle cancer	0.00863	0.00863	CcSEcCtD
Tapentadol—Weight decreased—Vincristine—muscle cancer	0.00847	0.00847	CcSEcCtD
Tapentadol—Depression—Vincristine—muscle cancer	0.00833	0.00833	CcSEcCtD
Tapentadol—Feeling hot—Doxorubicin—muscle cancer	0.00799	0.00799	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Etoposide—muscle cancer	0.00774	0.00774	CcSEcCtD
Tapentadol—Dysarthria—Methotrexate—muscle cancer	0.00766	0.00766	CcSEcCtD
Tapentadol—Chills—Dactinomycin—muscle cancer	0.00753	0.00753	CcSEcCtD
Tapentadol—Hallucination—Vincristine—muscle cancer	0.00746	0.00746	CcSEcCtD
Tapentadol—Hypoaesthesia—Vincristine—muscle cancer	0.00746	0.00746	CcSEcCtD
Tapentadol—Urinary tract disorder—Vincristine—muscle cancer	0.0074	0.0074	CcSEcCtD
Tapentadol—Connective tissue disorder—Vincristine—muscle cancer	0.00737	0.00737	CcSEcCtD
Tapentadol—Urethral disorder—Vincristine—muscle cancer	0.00735	0.00735	CcSEcCtD
Tapentadol—Depressed level of consciousness—Methotrexate—muscle cancer	0.007	0.007	CcSEcCtD
Tapentadol—Cardiac disorder—Vincristine—muscle cancer	0.00696	0.00696	CcSEcCtD
Tapentadol—Thinking abnormal—Doxorubicin—muscle cancer	0.00685	0.00685	CcSEcCtD
Tapentadol—Angiopathy—Vincristine—muscle cancer	0.0068	0.0068	CcSEcCtD
Tapentadol—Infestation NOS—Etoposide—muscle cancer	0.00677	0.00677	CcSEcCtD
Tapentadol—Infestation—Etoposide—muscle cancer	0.00677	0.00677	CcSEcCtD
Tapentadol—Mediastinal disorder—Vincristine—muscle cancer	0.00676	0.00676	CcSEcCtD
Tapentadol—Dysarthria—Doxorubicin—muscle cancer	0.00663	0.00663	CcSEcCtD
Tapentadol—Mental disorder—Vincristine—muscle cancer	0.00657	0.00657	CcSEcCtD
Tapentadol—Coordination abnormal—Doxorubicin—muscle cancer	0.00639	0.00639	CcSEcCtD
Tapentadol—Abnormal dreams—Doxorubicin—muscle cancer	0.0062	0.0062	CcSEcCtD
Tapentadol—Hypoaesthesia—Etoposide—muscle cancer	0.00604	0.00604	CcSEcCtD
Tapentadol—Urinary tract disorder—Etoposide—muscle cancer	0.006	0.006	CcSEcCtD
Tapentadol—Agitation—Vincristine—muscle cancer	0.006	0.006	CcSEcCtD
Tapentadol—Oedema—Dactinomycin—muscle cancer	0.00596	0.00596	CcSEcCtD
Tapentadol—Urethral disorder—Etoposide—muscle cancer	0.00595	0.00595	CcSEcCtD
Tapentadol—Infection—Dactinomycin—muscle cancer	0.00592	0.00592	CcSEcCtD
Tapentadol—Vertigo—Vincristine—muscle cancer	0.00586	0.00586	CcSEcCtD
Tapentadol—Eye disorder—Etoposide—muscle cancer	0.00568	0.00568	CcSEcCtD
Tapentadol—Convulsion—Vincristine—muscle cancer	0.00566	0.00566	CcSEcCtD
Tapentadol—Cardiac disorder—Etoposide—muscle cancer	0.00564	0.00564	CcSEcCtD
Tapentadol—Visual disturbance—Methotrexate—muscle cancer	0.00555	0.00555	CcSEcCtD
Tapentadol—Angiopathy—Etoposide—muscle cancer	0.00551	0.00551	CcSEcCtD
Tapentadol—Immune system disorder—Etoposide—muscle cancer	0.00549	0.00549	CcSEcCtD
Tapentadol—Mediastinal disorder—Etoposide—muscle cancer	0.00547	0.00547	CcSEcCtD
Tapentadol—Chills—Etoposide—muscle cancer	0.00545	0.00545	CcSEcCtD
Tapentadol—Mental disability—Doxorubicin—muscle cancer	0.00544	0.00544	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00543	0.00543	CcSEcCtD
Tapentadol—Lethargy—Methotrexate—muscle cancer	0.00537	0.00537	CcSEcCtD
Tapentadol—Anaphylactic shock—Vincristine—muscle cancer	0.00533	0.00533	CcSEcCtD
Tapentadol—Oedema—Vincristine—muscle cancer	0.00533	0.00533	CcSEcCtD
Tapentadol—Infection—Vincristine—muscle cancer	0.00529	0.00529	CcSEcCtD
Tapentadol—Osteoarthritis—Methotrexate—muscle cancer	0.00526	0.00526	CcSEcCtD
Tapentadol—Nervous system disorder—Vincristine—muscle cancer	0.00522	0.00522	CcSEcCtD
Tapentadol—Decreased appetite—Dactinomycin—muscle cancer	0.00518	0.00518	CcSEcCtD
Tapentadol—Hyperhidrosis—Vincristine—muscle cancer	0.00515	0.00515	CcSEcCtD
Tapentadol—Fatigue—Dactinomycin—muscle cancer	0.00514	0.00514	CcSEcCtD
Tapentadol—Irritability—Methotrexate—muscle cancer	0.00502	0.00502	CcSEcCtD
Tapentadol—Hypotension—Vincristine—muscle cancer	0.00498	0.00498	CcSEcCtD
Tapentadol—Ataxia—Methotrexate—muscle cancer	0.00494	0.00494	CcSEcCtD
Tapentadol—Feeling abnormal—Dactinomycin—muscle cancer	0.00491	0.00491	CcSEcCtD
Tapentadol—Hot flush—Doxorubicin—muscle cancer	0.00487	0.00487	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00485	0.00485	CcSEcCtD
Tapentadol—Menopausal symptoms—Doxorubicin—muscle cancer	0.00483	0.00483	CcSEcCtD
Tapentadol—Insomnia—Vincristine—muscle cancer	0.00482	0.00482	CcSEcCtD
Tapentadol—Paraesthesia—Vincristine—muscle cancer	0.00478	0.00478	CcSEcCtD
Tapentadol—Breast disorder—Methotrexate—muscle cancer	0.00475	0.00475	CcSEcCtD
Tapentadol—Vertigo—Etoposide—muscle cancer	0.00475	0.00475	CcSEcCtD
Tapentadol—Loss of consciousness—Etoposide—muscle cancer	0.00465	0.00465	CcSEcCtD
Tapentadol—Lethargy—Doxorubicin—muscle cancer	0.00465	0.00465	CcSEcCtD
Tapentadol—Decreased appetite—Vincristine—muscle cancer	0.00463	0.00463	CcSEcCtD
Tapentadol—Cough—Etoposide—muscle cancer	0.00461	0.00461	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Vincristine—muscle cancer	0.0046	0.0046	CcSEcCtD
Tapentadol—Fatigue—Vincristine—muscle cancer	0.00459	0.00459	CcSEcCtD
Tapentadol—Convulsion—Etoposide—muscle cancer	0.00458	0.00458	CcSEcCtD
Tapentadol—Constipation—Vincristine—muscle cancer	0.00456	0.00456	CcSEcCtD
Tapentadol—Osteoarthritis—Doxorubicin—muscle cancer	0.00455	0.00455	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00447	0.00447	CcSEcCtD
Tapentadol—Hypersensitivity—Dactinomycin—muscle cancer	0.00439	0.00439	CcSEcCtD
Tapentadol—Abdominal discomfort—Methotrexate—muscle cancer	0.00436	0.00436	CcSEcCtD
Tapentadol—Confusional state—Etoposide—muscle cancer	0.00435	0.00435	CcSEcCtD
Tapentadol—Anaphylactic shock—Etoposide—muscle cancer	0.00432	0.00432	CcSEcCtD
Tapentadol—Infection—Etoposide—muscle cancer	0.00429	0.00429	CcSEcCtD
Tapentadol—Ataxia—Doxorubicin—muscle cancer	0.00428	0.00428	CcSEcCtD
Tapentadol—Asthenia—Dactinomycin—muscle cancer	0.00428	0.00428	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00422	0.00422	CcSEcCtD
Tapentadol—Tachycardia—Etoposide—muscle cancer	0.00421	0.00421	CcSEcCtD
Tapentadol—Skin disorder—Etoposide—muscle cancer	0.00419	0.00419	CcSEcCtD
Tapentadol—Erectile dysfunction—Methotrexate—muscle cancer	0.00419	0.00419	CcSEcCtD
Tapentadol—Hyperhidrosis—Etoposide—muscle cancer	0.00417	0.00417	CcSEcCtD
Tapentadol—Breast disorder—Doxorubicin—muscle cancer	0.00412	0.00412	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.0041	0.0041	CcSEcCtD
Tapentadol—Diarrhoea—Dactinomycin—muscle cancer	0.00408	0.00408	CcSEcCtD
Tapentadol—Nasopharyngitis—Doxorubicin—muscle cancer	0.00407	0.00407	CcSEcCtD
Tapentadol—Infestation NOS—Methotrexate—muscle cancer	0.00405	0.00405	CcSEcCtD
Tapentadol—Infestation—Methotrexate—muscle cancer	0.00405	0.00405	CcSEcCtD
Tapentadol—Depression—Methotrexate—muscle cancer	0.00404	0.00404	CcSEcCtD
Tapentadol—Hypotension—Etoposide—muscle cancer	0.00403	0.00403	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00402	0.00402	CcSEcCtD
Tapentadol—Hypersensitivity—Vincristine—muscle cancer	0.00392	0.00392	CcSEcCtD
Tapentadol—Paraesthesia—Etoposide—muscle cancer	0.00387	0.00387	CcSEcCtD
Tapentadol—Dyspnoea—Etoposide—muscle cancer	0.00385	0.00385	CcSEcCtD
Tapentadol—Somnolence—Etoposide—muscle cancer	0.00384	0.00384	CcSEcCtD
Tapentadol—Asthenia—Vincristine—muscle cancer	0.00382	0.00382	CcSEcCtD
Tapentadol—Vomiting—Dactinomycin—muscle cancer	0.00379	0.00379	CcSEcCtD
Tapentadol—Rash—Dactinomycin—muscle cancer	0.00376	0.00376	CcSEcCtD
Tapentadol—Decreased appetite—Etoposide—muscle cancer	0.00375	0.00375	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Etoposide—muscle cancer	0.00373	0.00373	CcSEcCtD
Tapentadol—Fatigue—Etoposide—muscle cancer	0.00372	0.00372	CcSEcCtD
Tapentadol—Constipation—Etoposide—muscle cancer	0.00369	0.00369	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00366	0.00366	CcSEcCtD
Tapentadol—Diarrhoea—Vincristine—muscle cancer	0.00364	0.00364	CcSEcCtD
Tapentadol—Pollakiuria—Doxorubicin—muscle cancer	0.00364	0.00364	CcSEcCtD
Tapentadol—Urinary tract disorder—Methotrexate—muscle cancer	0.00359	0.00359	CcSEcCtD
Tapentadol—Urethral disorder—Methotrexate—muscle cancer	0.00357	0.00357	CcSEcCtD
Tapentadol—Weight decreased—Doxorubicin—muscle cancer	0.00356	0.00356	CcSEcCtD
Tapentadol—Feeling abnormal—Etoposide—muscle cancer	0.00356	0.00356	CcSEcCtD
Tapentadol—Nausea—Dactinomycin—muscle cancer	0.00354	0.00354	CcSEcCtD
Tapentadol—Dizziness—Vincristine—muscle cancer	0.00352	0.00352	CcSEcCtD
Tapentadol—Infestation NOS—Doxorubicin—muscle cancer	0.00351	0.00351	CcSEcCtD
Tapentadol—Infestation—Doxorubicin—muscle cancer	0.00351	0.00351	CcSEcCtD
Tapentadol—Visual impairment—Methotrexate—muscle cancer	0.00351	0.00351	CcSEcCtD
Tapentadol—Urticaria—Etoposide—muscle cancer	0.00343	0.00343	CcSEcCtD
Tapentadol—Urinary tract infection—Doxorubicin—muscle cancer	0.00341	0.00341	CcSEcCtD
Tapentadol—Eye disorder—Methotrexate—muscle cancer	0.0034	0.0034	CcSEcCtD
Tapentadol—Vomiting—Vincristine—muscle cancer	0.00339	0.00339	CcSEcCtD
Tapentadol—Cardiac disorder—Methotrexate—muscle cancer	0.00338	0.00338	CcSEcCtD
Tapentadol—Rash—Vincristine—muscle cancer	0.00336	0.00336	CcSEcCtD
Tapentadol—Dermatitis—Vincristine—muscle cancer	0.00336	0.00336	CcSEcCtD
Tapentadol—Headache—Vincristine—muscle cancer	0.00334	0.00334	CcSEcCtD
Tapentadol—Angiopathy—Methotrexate—muscle cancer	0.0033	0.0033	CcSEcCtD
Tapentadol—Immune system disorder—Methotrexate—muscle cancer	0.00329	0.00329	CcSEcCtD
Tapentadol—Mediastinal disorder—Methotrexate—muscle cancer	0.00328	0.00328	CcSEcCtD
Tapentadol—Chills—Methotrexate—muscle cancer	0.00326	0.00326	CcSEcCtD
Tapentadol—Bradycardia—Doxorubicin—muscle cancer	0.00321	0.00321	CcSEcCtD
Tapentadol—Mental disorder—Methotrexate—muscle cancer	0.00319	0.00319	CcSEcCtD
Tapentadol—Hypersensitivity—Etoposide—muscle cancer	0.00318	0.00318	CcSEcCtD
Tapentadol—Malnutrition—Methotrexate—muscle cancer	0.00317	0.00317	CcSEcCtD
Tapentadol—Nausea—Vincristine—muscle cancer	0.00316	0.00316	CcSEcCtD
Tapentadol—Hypoaesthesia—Doxorubicin—muscle cancer	0.00313	0.00313	CcSEcCtD
Tapentadol—Urinary tract disorder—Doxorubicin—muscle cancer	0.00311	0.00311	CcSEcCtD
Tapentadol—Asthenia—Etoposide—muscle cancer	0.0031	0.0031	CcSEcCtD
Tapentadol—Connective tissue disorder—Doxorubicin—muscle cancer	0.0031	0.0031	CcSEcCtD
Tapentadol—Urethral disorder—Doxorubicin—muscle cancer	0.00309	0.00309	CcSEcCtD
Tapentadol—Pruritus—Etoposide—muscle cancer	0.00305	0.00305	CcSEcCtD
Tapentadol—Visual impairment—Doxorubicin—muscle cancer	0.00304	0.00304	CcSEcCtD
Tapentadol—Vision blurred—Methotrexate—muscle cancer	0.00298	0.00298	CcSEcCtD
Tapentadol—Diarrhoea—Etoposide—muscle cancer	0.00295	0.00295	CcSEcCtD
Tapentadol—Eye disorder—Doxorubicin—muscle cancer	0.00294	0.00294	CcSEcCtD
Tapentadol—Cardiac disorder—Doxorubicin—muscle cancer	0.00292	0.00292	CcSEcCtD
Tapentadol—Angiopathy—Doxorubicin—muscle cancer	0.00286	0.00286	CcSEcCtD
Tapentadol—Dizziness—Etoposide—muscle cancer	0.00285	0.00285	CcSEcCtD
Tapentadol—Immune system disorder—Doxorubicin—muscle cancer	0.00285	0.00285	CcSEcCtD
Tapentadol—Vertigo—Methotrexate—muscle cancer	0.00285	0.00285	CcSEcCtD
Tapentadol—Mediastinal disorder—Doxorubicin—muscle cancer	0.00284	0.00284	CcSEcCtD
Tapentadol—Chills—Doxorubicin—muscle cancer	0.00283	0.00283	CcSEcCtD
Tapentadol—Cough—Methotrexate—muscle cancer	0.00276	0.00276	CcSEcCtD
Tapentadol—Mental disorder—Doxorubicin—muscle cancer	0.00276	0.00276	CcSEcCtD
Tapentadol—Convulsion—Methotrexate—muscle cancer	0.00274	0.00274	CcSEcCtD
Tapentadol—Vomiting—Etoposide—muscle cancer	0.00274	0.00274	CcSEcCtD
Tapentadol—Malnutrition—Doxorubicin—muscle cancer	0.00274	0.00274	CcSEcCtD
Tapentadol—Rash—Etoposide—muscle cancer	0.00272	0.00272	CcSEcCtD
Tapentadol—Dermatitis—Etoposide—muscle cancer	0.00272	0.00272	CcSEcCtD
Tapentadol—Headache—Etoposide—muscle cancer	0.0027	0.0027	CcSEcCtD
Tapentadol—Arthralgia—Methotrexate—muscle cancer	0.0027	0.0027	CcSEcCtD
Tapentadol—Tension—Doxorubicin—muscle cancer	0.00269	0.00269	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00268	0.00268	CcSEcCtD
Tapentadol—Nervousness—Doxorubicin—muscle cancer	0.00266	0.00266	CcSEcCtD
Tapentadol—Confusional state—Methotrexate—muscle cancer	0.00261	0.00261	CcSEcCtD
Tapentadol—Anaphylactic shock—Methotrexate—muscle cancer	0.00258	0.00258	CcSEcCtD
Tapentadol—Vision blurred—Doxorubicin—muscle cancer	0.00258	0.00258	CcSEcCtD
Tapentadol—Infection—Methotrexate—muscle cancer	0.00257	0.00257	CcSEcCtD
Tapentadol—Nausea—Etoposide—muscle cancer	0.00256	0.00256	CcSEcCtD
Tapentadol—Nervous system disorder—Methotrexate—muscle cancer	0.00253	0.00253	CcSEcCtD
Tapentadol—Agitation—Doxorubicin—muscle cancer	0.00252	0.00252	CcSEcCtD
Tapentadol—Skin disorder—Methotrexate—muscle cancer	0.00251	0.00251	CcSEcCtD
Tapentadol—Hyperhidrosis—Methotrexate—muscle cancer	0.0025	0.0025	CcSEcCtD
Tapentadol—Vertigo—Doxorubicin—muscle cancer	0.00246	0.00246	CcSEcCtD
Tapentadol—Syncope—Doxorubicin—muscle cancer	0.00246	0.00246	CcSEcCtD
Tapentadol—Palpitations—Doxorubicin—muscle cancer	0.00242	0.00242	CcSEcCtD
Tapentadol—Hypotension—Methotrexate—muscle cancer	0.00242	0.00242	CcSEcCtD
Tapentadol—Loss of consciousness—Doxorubicin—muscle cancer	0.00241	0.00241	CcSEcCtD
Tapentadol—Cough—Doxorubicin—muscle cancer	0.00239	0.00239	CcSEcCtD
Tapentadol—Convulsion—Doxorubicin—muscle cancer	0.00238	0.00238	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00235	0.00235	CcSEcCtD
Tapentadol—Insomnia—Methotrexate—muscle cancer	0.00234	0.00234	CcSEcCtD
Tapentadol—Arthralgia—Doxorubicin—muscle cancer	0.00233	0.00233	CcSEcCtD
Tapentadol—Anxiety—Doxorubicin—muscle cancer	0.00233	0.00233	CcSEcCtD
Tapentadol—Paraesthesia—Methotrexate—muscle cancer	0.00232	0.00232	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00232	0.00232	CcSEcCtD
Tapentadol—Dyspnoea—Methotrexate—muscle cancer	0.0023	0.0023	CcSEcCtD
Tapentadol—Somnolence—Methotrexate—muscle cancer	0.0023	0.0023	CcSEcCtD
Tapentadol—Dry mouth—Doxorubicin—muscle cancer	0.00228	0.00228	CcSEcCtD
Tapentadol—Dyspepsia—Methotrexate—muscle cancer	0.00228	0.00228	CcSEcCtD
Tapentadol—Confusional state—Doxorubicin—muscle cancer	0.00226	0.00226	CcSEcCtD
Tapentadol—Decreased appetite—Methotrexate—muscle cancer	0.00225	0.00225	CcSEcCtD
Tapentadol—Anaphylactic shock—Doxorubicin—muscle cancer	0.00224	0.00224	CcSEcCtD
Tapentadol—Oedema—Doxorubicin—muscle cancer	0.00224	0.00224	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00223	0.00223	CcSEcCtD
Tapentadol—Fatigue—Methotrexate—muscle cancer	0.00223	0.00223	CcSEcCtD
Tapentadol—Infection—Doxorubicin—muscle cancer	0.00222	0.00222	CcSEcCtD
Tapentadol—Shock—Doxorubicin—muscle cancer	0.0022	0.0022	CcSEcCtD
Tapentadol—Nervous system disorder—Doxorubicin—muscle cancer	0.00219	0.00219	CcSEcCtD
Tapentadol—Tachycardia—Doxorubicin—muscle cancer	0.00218	0.00218	CcSEcCtD
Tapentadol—Skin disorder—Doxorubicin—muscle cancer	0.00217	0.00217	CcSEcCtD
Tapentadol—Hyperhidrosis—Doxorubicin—muscle cancer	0.00216	0.00216	CcSEcCtD
Tapentadol—Feeling abnormal—Methotrexate—muscle cancer	0.00213	0.00213	CcSEcCtD
Tapentadol—Hypotension—Doxorubicin—muscle cancer	0.00209	0.00209	CcSEcCtD
Tapentadol—Urticaria—Methotrexate—muscle cancer	0.00205	0.00205	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00204	0.00204	CcSEcCtD
Tapentadol—Insomnia—Doxorubicin—muscle cancer	0.00202	0.00202	CcSEcCtD
Tapentadol—Paraesthesia—Doxorubicin—muscle cancer	0.00201	0.00201	CcSEcCtD
Tapentadol—Dyspnoea—Doxorubicin—muscle cancer	0.002	0.002	CcSEcCtD
Tapentadol—Somnolence—Doxorubicin—muscle cancer	0.00199	0.00199	CcSEcCtD
Tapentadol—Dyspepsia—Doxorubicin—muscle cancer	0.00197	0.00197	CcSEcCtD
Tapentadol—Decreased appetite—Doxorubicin—muscle cancer	0.00195	0.00195	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00193	0.00193	CcSEcCtD
Tapentadol—Fatigue—Doxorubicin—muscle cancer	0.00193	0.00193	CcSEcCtD
Tapentadol—Constipation—Doxorubicin—muscle cancer	0.00191	0.00191	CcSEcCtD
Tapentadol—Hypersensitivity—Methotrexate—muscle cancer	0.0019	0.0019	CcSEcCtD
Tapentadol—Asthenia—Methotrexate—muscle cancer	0.00185	0.00185	CcSEcCtD
Tapentadol—Feeling abnormal—Doxorubicin—muscle cancer	0.00184	0.00184	CcSEcCtD
Tapentadol—Pruritus—Methotrexate—muscle cancer	0.00183	0.00183	CcSEcCtD
Tapentadol—Urticaria—Doxorubicin—muscle cancer	0.00178	0.00178	CcSEcCtD
Tapentadol—Diarrhoea—Methotrexate—muscle cancer	0.00177	0.00177	CcSEcCtD
Tapentadol—Dizziness—Methotrexate—muscle cancer	0.00171	0.00171	CcSEcCtD
Tapentadol—Hypersensitivity—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Tapentadol—Vomiting—Methotrexate—muscle cancer	0.00164	0.00164	CcSEcCtD
Tapentadol—Rash—Methotrexate—muscle cancer	0.00163	0.00163	CcSEcCtD
Tapentadol—Dermatitis—Methotrexate—muscle cancer	0.00163	0.00163	CcSEcCtD
Tapentadol—Headache—Methotrexate—muscle cancer	0.00162	0.00162	CcSEcCtD
Tapentadol—Asthenia—Doxorubicin—muscle cancer	0.00161	0.00161	CcSEcCtD
Tapentadol—Pruritus—Doxorubicin—muscle cancer	0.00158	0.00158	CcSEcCtD
Tapentadol—Nausea—Methotrexate—muscle cancer	0.00154	0.00154	CcSEcCtD
Tapentadol—Diarrhoea—Doxorubicin—muscle cancer	0.00153	0.00153	CcSEcCtD
Tapentadol—Dizziness—Doxorubicin—muscle cancer	0.00148	0.00148	CcSEcCtD
Tapentadol—Vomiting—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Tapentadol—Rash—Doxorubicin—muscle cancer	0.00141	0.00141	CcSEcCtD
Tapentadol—Dermatitis—Doxorubicin—muscle cancer	0.00141	0.00141	CcSEcCtD
Tapentadol—Headache—Doxorubicin—muscle cancer	0.0014	0.0014	CcSEcCtD
Tapentadol—Nausea—Doxorubicin—muscle cancer	0.00133	0.00133	CcSEcCtD
